Dr Kaina L Steward, | |
1624 N Burnside Ave, Gonzales, LA 70737-2139 | |
(225) 644-7528 | |
Not Available |
Full Name | Dr Kaina L Steward |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1624 N Burnside Ave, Gonzales, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013290279 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 17899 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kaina L Steward, 1624 N Burnside Ave, Gonzales, LA 70737-2139 Ph: (225) 644-7528 | Dr Kaina L Steward, 1624 N Burnside Ave, Gonzales, LA 70737-2139 Ph: (225) 644-7528 |
News Archive
Despite a 1990 consensus recommendation from the National Institutes of Health (NIH) that lumpectomy plus radiation was the treatment of choice for early stage breast cancer, the United States continues to have the highest rate of mastectomy surgery among industrialized countries.
"Just as dealings with the Obama administration and congressional Democrats soured last summer, six of the nation's biggest health insurers began quietly pumping big money into third-party television ads aimed at killing or significantly modifying the major health reform bills moving through Congress," The National Journal reports.
Patients who were asked where they wanted to die upon entering hospice had lower rates of hospitalization at the end of life, as did those in hospices that monitored symptoms more frequently, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.
XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of unmet clinical needs with a focus on treatments for autoimmune diseases, today announced that it has reached agreement with Yeda Research and Development Company Ltd. to amend the development milestones in the License Agreement signed between the parties in January 2014 for the development of hCDR1 for the treatment of systemic lupus erythematosus (SLE).
› Verified 7 days ago
Carolyn P Lancon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 S Burnside Ave, Gonzales, LA 70737 Phone: 225-644-5622 | |
Jeanne J Bertrand, RPH, MA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 S Burnside Ave, Gonzales, LA 70737 Phone: 225-644-5641 Fax: 225-644-0353 | |
Brittany Dean, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1607 N Airline Hwy, Gonzales, LA 70737 Phone: 225-644-3871 | |
Trineqa Adams, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1624 N Burnside Ave, Gonzales, LA 70737 Phone: 225-644-7528 | |
Stephanie Stampley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15013-b Hwy 44, Gonzales, LA 70737 Phone: 225-622-0445 | |
Joseph Steven Harris, BSPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1817 S Burnside Ave, Gonzales, LA 70737 Phone: 225-644-3030 Fax: 225-647-2706 |